My understanding is that Ximedica is doing all the ground work for the European (CE Mark) and FDA approvals. I'd hope they are deep into this process and the protocol(s) for the clinical trials in the US are being written now. The FDA will need to inform Titan/Ximedica on the study design requirements so the protocols can be developed. Again, this the type of timeline information that can be shared but isn't.
News 
Market Data 
Discover 
